Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells

Biomaterials

Volumn 33, Issue 29, 2012, Pages 7126-7137

  Chen, Yu ^a   Yin, Qi ^b   Ji, Xiufeng ^b   Zhang, Shengjian ^d   Chen, Hangrong ^a   Zheng, Yuanyi ^c   Sun, Yang ^c   Qu, Haiyun ^a   Wang, Zheng ^a   Li, Yaping ^b   Wang, Xia ^a   Zhang, Kun ^a   Zhang, Linlin ^a   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Cancer therapy; Diagnosis; Hollow; Mesoporous; MRI; Ultrasonography

Indexed keywords

ACIDIC CONDITIONS; ACIDIC MICROENVIRONMENT; ANTI-CANCER AGENTS; ANTIPROLIFERATIVE EFFECT; CANCER CELLS; CANCER IMAGING; CANCER THERAPY; COMPLEX AGENT; CONTRAST AGENT; DOXORUBICIN; DRUG RELEASE; DUAL-MODALITY; HOLLOW; HOLLOW MESOPOROUS SILICA NANOPARTICLES; HOLLOW NANOSTRUCTURES; IN-SITU; IN-VITRO; MESO-PORES; MESOPOROUS; MESOPOROUS COMPOSITES; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; MULTI-FUNCTIONALIZATION; MULTI-FUNCTIONALIZED; MULTIDRUG RESISTANCE; NEUTRAL CONDITIONS; OXIDE NANOPARTICLES; PH-RESPONSIVE; RELAXATION RATES; THERANOSTICS;

CELLS; DIAGNOSIS; ENZYME ACTIVITY; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MANGANESE; MEDICAL IMAGING; NANOPARTICLES; OXIDES; REDOX REACTIONS; ULTRASONOGRAPHY;

MANGANESE OXIDE;

CONTRAST MEDIUM; DOXORUBICIN; GADOLINIUM; GLYCOPROTEIN P; HOLLOW MESOPOROUS SILICA NANOPARTICLE; HYBRID MESOPOROUS COMPOSITE NANOCAPSULE; MANGANESE OXIDE; NANOCAPSULE; NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; B SCAN; CANCER CELL; CONFOCAL LASER MICROSCOPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ECHOGRAPHY; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; HARMONIC MODE ECHOGRAPHY; HOLLOW FIBER; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION REACTION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

ADSORPTION; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; MICROSCOPY, CONFOCAL; NANOTECHNOLOGY; NEOPLASMS; OXIDATION-REDUCTION; OXIDES; POLYETHYLENE GLYCOLS; SILICON DIOXIDE; ULTRASONOGRAPHY;

EID: 84864290990     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.059     Document Type: Article

References (42)

1. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
2. Yavuz M.S., Cheng Y.Y., Chen J.Y., Cobley C.M., Zhang Q., Rycenga M., et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 2009, 8:935-939.
3. Lee J.H., Huh Y.M., Jun Y., Seo J., Jang J., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
4. Slowing, Vivero-Escoto J.L., Wu C.W., Lin V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008, 60:1278-1288.
5. Lammers T., Aime S., Hennink W.E., Storm G., Kiessling F. Theranostic nanomedicine. Acc Chem Res 2011, 44:1029-1038.
6. Kievit F.M., Zhang M.Q. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 2011, 23:H217-H247.
7. Lammers T., Kiessling F., Hennink W.E., Storm G. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Phar 2010, 7:1899-1912.
8. Malvindi M.A., Greco A., Conversano F., Figuerola A., Corti M., Bonora M., et al. Magnetic/silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv Funct Mater 2011, 21:2548-2555.
9. Park J.I., Jagadeesan D., Williams R., Oakden W., Chung S.Y., Stanisz G.J., et al. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities. ACS Nano 2010, 4:6579-6586.
10. Shin J.M., Anisur R.M., Ko M.K., Im G.H., Lee J.H., Lee I.S. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed 2009, 48:321-324.
11. 1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed 2007, 46:5397-5401.
12. 1-weighted MRI and simultaneous anti-cancer drug delivery. Biomaterials 2012, 33:2388-2398.
13. Peng Y.K., Lai C.W., Liu C.L., Chen H.C., Hsiao Y.H., Liu W.L., et al. A new and facile method to prepare uniform hollow MnO/functionalized mSiO(2) core/shell nanocomposites. ACS Nano 2011, 5:4177-4187.
14. 1 contrast agents for labeling and MRI tracking of adipose-derived mesenchyrnal stem cells. J Am Chem Soc 2011, 133:2955-2961.
15. Penfield J.G., Reilly R.F. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007, 3:654-668.
16. 1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. Nano Lett 2009, 9:4434-4440.
17. Perez-Rodriguez J., Lai S., Ehst B.D., Fine D.M., Bluemke D.A. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases. Radiology 2009, 250:371-377.
18. Crayton S.H., Tsourkas A. pH-titratable superparamagnetic iron oxide for improved nanoparticle accumulation in acidic tumor microenvironments. ACS Nano 2011, 5:9592-9601.
19. + diffusion to the acidic pH of tumors. Neoplasia 2003, 5:135-145.
20. 1 contrast agents for magnetic resonance imaging. Angew Chem Int Ed 2011, 50:10589-10593.
21. Torres E., Mainini F., Napolitano R., Fedeli F., Cavalli R., Aime S., et al. Improved paramagnetic liposomes for MRI visualization of pH triggered release. J Control Release 2011, 154:196-202.
22. Bennewitz M.F., Lobo T.L., Nkansah M.K., Ulas G., Brudvig G.W., Shapiro E.M. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011, 5:3438-3446.
23. Wang X., Chen H., Chen Y., Ma M., Zhang K., Li F., et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 2012, 24:785-791.
24. Lin P.L., Eckersley R.J., Hall E.A.H. Ultrabubble: a laminated ultrasound contrast agent with narrow size range. Adv Mater 2009, 21:3949-3952.
25. Hu H., Zhou H., Du J., Wang Z.Q., An L., Yang H., et al. Biocompatiable hollow silica microspheres as novel ultrasound contrast agents for in vivo imaging. J Mater Chem 2011, 21:6576-6583.
26. Martinez H.P., Kono Y., Blair S.L., Sandoval S., Wang-Rodriguez J., Mattrey R.F., et al. Hard shell gas-filled contrast enhancement particles for color Doppler ultrasound imaging of tumors. Medchemcomm 2010, 1:266-270.
27. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
28. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007, 46:7548-7558.
29. Lee C.H., Cheng S.H., Huang I.P., Souris J.S., Yang C.S., Mou C.Y., et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Ed 2010, 49:8214-8219.
30. Park C., Oh K., Lee S.C., Kim C. Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. Angew Chem Int Ed 2007, 46:1455-1457.
31. Chen Y., Chen H.R., Guo L.M., He Q.J., Chen F., Zhou J., et al. Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 2010, 4:529-539.
32. Chen Y., Chen H.R., Zeng D.P., Tian Y.B., Chen F., Feng J.W., et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010, 4:6001-6013.
33. Chen Y., Chen H.R., Ma M., Chen F., Guo L.M., Zhang L.X., et al. Double mesoporous silica shelled spherical/ellipsoidal nanostructures: synthesis and hydrophilic/hydrophobic anticancer drug delivery. J Mater Chem 2011, 21:5290-5298.
34. Chen Y., Chu C., Zhou Y.C., Ru Y.F., Chen H.R., Chen F., et al. Reversible pore-structure evolution in hollow silica nanocapsules: large pores for siRNA delivery and nanoparticle collecting. Small 2011, 7:2935-2944.
35. Taylor K.M.L., Kim J.S., Rieter W.J., An H., Lin W.L., Lin W.B. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 2008, 130:2154-2155.
36. Oeffinger B.E., Wheatley M.A. Development and characterization of a nano-scale contrast agent. Ultrasonics 2004, 42:343-347.
37. Chen Y., Gao Y., Chen H., Zeng D., Li Y., Zheng Y., et al. Engineering inorganic nanoemulsions/nanoliposomes by fluoride-silica chemistry for efficient delivery/co-delivery of hydrophobic agents. Adv Funct Mater 2012, 22:1586-1597.
38. Lee Y., Graeser R., Kratz F., Geckeler K.E. Paclitaxel-loaded polymer nanoparticles for the reversal of multidrug resistance in breast cancer cells. Adv Funct Mater 2011, 21:4211-4218.
39. Yan Y., Ochs C.J., Such G.K., Heath J.K., Nice E.C., Caruso F. Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules. Adv Mater 2010, 22:5398-5403.
40. Gao Y., Chen Y., Ji X.F., He X.Y., Yin Q., Zhang Z.W., et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 2011, 5:9788-9798.
41. Dong X.W., Mattingly C.A., Tseng M.T., Cho M.J., Liu Y., Adams V.R., et al. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res 2009, 69:3918-3926.
42. Liang X.J., Meng H., Wang Y.Z., He H.Y., Meng J., Lu J.W., et al. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A 2010, 107:7449-7454.